BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6441705)

  • 1. Inhibition of proteolytic cleavage of the hemagglutinin of influenza virus by the calcium-specific ionophore A23187.
    Klenk HD; Garten W; Rott R
    EMBO J; 1984 Dec; 3(12):2911-5. PubMed ID: 6441705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of influenza B virus hemagglutinin containing multibasic residue cleavage sites.
    Brassard DL; Lamb RA
    Virology; 1997 Sep; 236(2):234-48. PubMed ID: 9325231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A monoclonal antibody specific to the HA2 glycoprotein of influenza A virus hemagglutinin that inhibits its fusion activity reduces replication of the virus.
    Varecková E; Wharton SA; Mucha V; Gocník M; Kostolanský F
    Acta Virol; 2003; 47(4):229-36. PubMed ID: 15068378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition.
    Böttcher E; Freuer C; Steinmetzer T; Klenk HD; Garten W
    Vaccine; 2009 Oct; 27(45):6324-9. PubMed ID: 19840668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza virus M2 protein ion channel activity is not required to maintain the equine-1 hemagglutinin in its native form in infected cells.
    Takeuchi K; Shaughnessy MA; Lamb RA
    Virology; 1994 Aug; 202(2):1007-11. PubMed ID: 7518161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of fusion activity of influenza A haemagglutinin mediated by HA2-specific monoclonal antibodies.
    Varecková E; Mucha V; Wharton SA; Kostolanský F
    Arch Virol; 2003 Mar; 148(3):469-86. PubMed ID: 12607099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of influenza virus hemagglutinin-mediated membrane fusion by a compound related to podocarpic acid.
    Staschke KA; Hatch SD; Tang JC; Hornback WJ; Munroe JE; Colacino JM; Muesing MA
    Virology; 1998 Sep; 248(2):264-74. PubMed ID: 9721235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of edeine, hygromycin B and alpha-Sarcin on influenza virus reproduction.
    Ghendon YuZ ; Klimov AI
    Acta Virol; 1981 May; 25(3):129-37. PubMed ID: 6115560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell tropism of influenza virus mediated by hemagglutinin activation at the stage of virus entry.
    Boycott R; Klenk HD; Ohuchi M
    Virology; 1994 Sep; 203(2):313-9. PubMed ID: 8053155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new approach to an influenza live vaccine: modification of the cleavage site of hemagglutinin.
    Stech J; Garn H; Wegmann M; Wagner R; Klenk HD
    Nat Med; 2005 Jun; 11(6):683-9. PubMed ID: 15924146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a hemagglutinin-specific inhibitor of influenza A virus.
    Luo G; Colonno R; Krystal M
    Virology; 1996 Dec; 226(1):66-76. PubMed ID: 8941323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic mixing with recombinant haemagglutinin of high cleavability mediates multi-cycle replication of human influenza virus in cell culture.
    Kaverin NV; Ohuchi M; Ohuchi R; Klenk HD
    J Gen Virol; 1996 Jan; 77 ( Pt 1)():119-22. PubMed ID: 8558119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the role of oligosaccharide trimming in the maturation of Sindbis and influenza virus.
    Datema R; Romero PA; Rott R; Schwarz RT
    Arch Virol; 1984; 81(1-2):25-39. PubMed ID: 6743024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abortive infection of Vero cells by an influenza A virus (FPV).
    Lau SC; Scholtissek C
    Virology; 1995 Sep; 212(1):225-31. PubMed ID: 7676635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in caspase cleavage motifs of NP and M2 proteins attenuate virulence of a highly pathogenic avian influenza virus.
    Zhirnov OP; Klenk HD
    Virology; 2009 Nov; 394(1):57-63. PubMed ID: 19747708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a proteolytic enzyme inhbitor on influenza virus replication.
    Ruttkayová-Nedecká S; Russ G
    Acta Virol; 1977 Jan; 21(1):79-81. PubMed ID: 15441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of 2 influenza A(H3N2) clinical isolates with reduced susceptibility to neuraminidase inhibitors due to mutations in the hemagglutinin gene.
    Abed Y; Bourgault AM; Fenton RJ; Morley PJ; Gower D; Owens IJ; Tisdale M; Boivin G
    J Infect Dis; 2002 Oct; 186(8):1074-80. PubMed ID: 12355356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological characterization of FPV, Ulster 73, replicative cycle.
    Conti G; Portincasa P; Pesce A; Chezzi C
    Microbiologica; 1985 Apr; 8(2):151-64. PubMed ID: 4010527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The M1 and M2 proteins of influenza A virus are important determinants in filamentous particle formation.
    Roberts PC; Lamb RA; Compans RW
    Virology; 1998 Jan; 240(1):127-37. PubMed ID: 9448697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virulence factors of influenza A viruses: WSN virus neuraminidase required for plaque production in MDBK cells.
    Schulman JL; Palese P
    J Virol; 1977 Oct; 24(1):170-6. PubMed ID: 561860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.